JESSICA MAYS: Open Payments
NPI 1295024305 · TRUSSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 23 payments from 10 companies in 2025. Trend: 2023 $312 · 2024 $659 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $153 |
| Astellas Pharma US Inc | 5 | $132 |
| Lilly USA, LLC | 3 | $44 |
| Exact Sciences Corporation | 2 | $40 |
| Janssen Biotech, Inc. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Boston Scientific Corporation | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: Kerendia, Veozah, JARDIANCE, MOUNJARO, RYBREVANT, The Cologuard Plus Collection Kit, VOQUEZNA, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
